Glomerulonephritis

Publisher Website
Google Scholar
Abstract
ALMOST without exception, writers on glomerulonephritis begin by quoting Richard Bright. I shall not do so. Bright has been overworked. Indeed, since this effort will stress pathogenesis and therapy rather than morphology and clinical manifestations, the words of a more recent observer of the biologic scene seem more appropriate. Thomas1 refers to kidney transplantation and by inference chronic hemodialysis as a "halfway technology." By this he means a technology that compensates for established disease or postpones death in such states. He makes the point that halfway technologies are enormously expensive in contrast to "high technologies" such as immunization against poliomyelitis, . . .